Daniel S Berman MD

Nuclear Medicine•Los Angeles, CA

Professor, Medicine, UCLA School of Medicine

Join to View Full Profile

8700 Beverly BlvdRm M335Los Angeles, CA 90048
Phone+1 310-423-8000
Fax+1 805-375-8900

Education & Training

University of California Davis HealthResidency, Radiology-Diagnostic, 1972 - 1973
University of California Davis HealthResidency, Internal Medicine, 1970 - 1972
University of California Davis HealthInternship, Internal Medicine, 1969 - 1970
University of California San Francisco School of MedicineClass of 1969

Certifications & Licensure

CA State Medical License 1970 - 2026
NV State Medical License 2011 - 2021
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease
American Board of Nuclear Medicine Nuclear Medicine

Awards, Honors, & Recognition

Fellow (FACC) American College of Cardiology

Clinical Trials

Adenosine Dual Source Computed Tomography (CT) Versus Adenosine Single Photon Emission Computed Tomography (SPECT) Start of enrollment: 2007 Feb 01
Completed
Early Identification of Subclinical Atherosclerosis Using Non-Invasive Imaging Research (EISNER) Start of enrollment: 2001 Feb 01
Completed
Not Applicable
A Long-term Follow-up Study to Evaluate the Predictive Value of BMS747158 in Patients Suspected of Coronary Artery Disease (CAD) Start of enrollment: 2013 Mar 01
Withdrawn
Treatment With Ranolazine in Microvascular Coronary Dysfunction (MCD): Impact on Angina Myocardial Ischemia Start of enrollment: 2011 May 01
Completed
Not Applicable
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD. Start of enrollment: 2011 Jun 01
Completed
Phase 3
Artifact-Free High-Resolution Myocardial Perfusion MRI in Subjects With Abnormal Nuclear Myocardial Perfusion Studies Start of enrollment: 2014 May 16
Completed
Not Applicable
Identification of Adverse Plaque Characteristics by Coronary MR Angiography Start of enrollment: 2012 Apr 01
Completed
Not Applicable
Calibration of MR and PET-MR Imaging Protocols at RIC
WITHDRAWN
NA
18F-fluoride (18F-NaF) PET for Identifying Coronary Atherosclerotic Plaques Start of enrollment: 2015 Nov 13
Completed
Phase 4
18-F Sodium Fluoride (18F-NaF) PET for the Assessment of Bioprosthetic Aortic Valve Durability and Outcomes Start of enrollment: 2017 Jul 23
COMPLETED
PHASE2
Join now to see all

Publications & Presentations

PubMed

Artificial Intelligence-Enhanced Perfusion Scoring Improves the Diagnostic Accuracy of Myocardial Perfusion Imaging.
Robert J H Miller, Paul Kavanagh, Mark Lemley, Joanna X Liang, Tali Sharir
Journal of Nuclear Medicine. 2025-04-01
Myocardial biomarkers in coronary microvascular dysfunction: Response to ranolazine.
Katherine E Hampilos, Anum Asif, Puja K Mehta, Daniel S Berman, Galen Cook-Wiens
American Heart Journal Plus. 2025-04-01
Deep learning-quantified body composition from positron emission tomography/computed tomography and cardiovascular outcomes: a multicentre study.
Robert J H Miller, Jirong Yi, Aakash Shanbhag, Anna Marcinkiewicz, Krishna K Patel
European Heart Journal. 2025-03-30

Journal Articles

Original Research Deep Learning for Prediction of Obstructive Disease from Fast Myocardial Perfusion SPECT: A Multicenter Study
Sabahat Bokhari, Sharmila Dorbala, Timothy M Bateman, Andrew J Einstein, Mathews B Fish, Balaji K Tamarappoo, Albert J Sinusas, Daniel S Berman, ScienceDirect
Prognostic Value of Vasodilator Response Using Rubidium-82 Positron Emission Tomography Myocardial Perfusion Imaging in Patients with Coronary Artery Disease
Sharmila Dorbala, Daniel S Berman, Michael E Merhige, James K Min, European Journal of Nuclear Medicine and Molecular Imaging

Professional Memberships

American College of Cardiology - ACC
Fellow
American Society of Nuclear Cardiology - ASNC
Fellow
Society of Cardiovascular CT (SCCT)
Fellow
American Heart Association - AHA
Fellow